GLP-1 medication use was associated with lower mortality among colon cancer patients, according to a study published Nov. 11 in Cancer Investigation. Researchers from the University of California San Diego used real-world clinical data from the University of California Health…
Author: Elizabeth Gregerson
Rates of timely screening, surveillance and diagnostic testing for cervical cancer lag behind rates for colorectal and lung cancer, according to a study published Sept. 10 in the Journal of the National Cancer Institute. Researchers used data from 10 health…
Duarte, Calif.-based City of Hope has tapped Christine Lovly, MD, PhD, to develop and lead the system’s national thoracic oncology program. Dr. Lovly will serve as division chief of thoracic medical oncology and as professor in the department of medical…
Gainesville, Fla.-based UF Health has named Thomas George, MD, interim director of the University of Florida Health Cancer Institute. Dr. George was the institute’s associate director of clinical research for seven years before he began serving as deputy director in…
The Herbert Irving Comprehensive Cancer Center at New York City-based NewYork-Presbyterian/Columbia University Irving Medical Center has earned renewed designation as a comprehensive cancer center by the National Cancer Institute. The five-year renewal comes with $26.9 million in funding, according to…
Advertisement
Michael Kastan, MD, PhD, is stepping down as executive director of the Duke Cancer Institute, a position he has held since 2011. The Duke Cancer Institute is part of Durham, N.C.-based Duke University Health System. Dr. Kastan is the inaugural…
Miami-based Sylvester Comprehensive Cancer Center has launched the Sylvester Survivorship and Supportive Care Institute. Frank Penedo, PhD, will serve as the institute’s director alongside Carmen Calfa, MD, as co-director and medical director, according to an Oct. 30 news release from…
Boston-based Dana-Farber Cancer Institute received a $78 million gift from the Pan-Mass Challenge, an annual bike-a-thon across Massachusetts. Since its foundation in 1980, the event has raised $1.125 billion for Dana-Farber, according to a Nov. 2 news release from the…
Not every critical innovation in cancer care comes from a Phase III trial or a new drug approval. Sometimes, progress comes from a new onboarding curriculum that improves how nurses acclimate to a high-acuity unit. It could come from a…
As Breast Cancer Awareness Month comes to a close, Becker’s asked oncology leaders from hospitals and health systems across the U.S. how their organizations are supporting technological innovation in breast cancer care. From contrast enhanced mammography to AI integration, here…